GFPC
REGN icon

Global Financial Private Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Global Financial Private Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.34M Sell
2,151
-390
-15% -$221K 0.08% 184
2020
Q1 		$1.24M Buy
+2,541
New +$1.05M 0.08% 182

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Global Financial Private Capital's REGN Position: Q2 2020 in Review

Global Financial Private Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2020, selling an estimated $221K and leaving 2,151 shares worth $1.34M. The position accounts for 0.08% of the portfolio, ranked #184.

Global Financial Private Capital first reported a position in REGN in Q1 2020 and has held it in 2 quarters since. 933 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Global Financial Private Capital held 2,151 shares of Regeneron Pharmaceuticals worth $1.34M as of Q2 2020.
  • Global Financial Private Capital sold 390 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $221K.
  • Regeneron Pharmaceuticals made up 0.08% of Global Financial Private Capital's portfolio in Q2 2020, its #184 holding.
  • Global Financial Private Capital first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 2 quarters since.
  • 933 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.